Roche will report new data on important progress for people with advanced cancers at ASCO 2012
Data from AURELIA, the first Phase III study of Avastin plus
chemotherapy in people with platinum-resistant recurrent ovarian cancer
will be presented. This study will be highlighted as part of ASCO’s
official press program.
An ovarian cancer blog which includes quality resource materials: education, research, social networking, genetics and (some) healthcare politics.
“Not everything that can be counted counts and not everything that counts can be counted.”
Albert Einstein
No comments:
Post a Comment
Your comments?
Note: Only a member of this blog may post a comment.